Krishma Shah, The Co-Founder of Clinibiz

Krishma Shah, a Forbes India 30 under 30 2022 recipient, is the co-Founder of Clinibiz, which is a research enterprise that partners with investigators to expand new and existing research initiatives in the clinical trials industry. CliniBiz treats the clinical trial model as a business by crafting operational and quality management workflows that oversee study operations. To close the gap between sponsor and study site needs, CliniBiz ensures a good match between the study and investigator.

Shah, who had previously studied biotechnology at Mumbai’s Jai Hind College, graduated in 2015 from the prestigious Columbia University among the youngest students in her class with a concentration in genetics and immunology. When she was 23, she worked with Dr. Ian Lipkin at the Centre for Infection and Immunology to perform respiratory virus research. After that, she wanted to do more to make science accessible to everyone, not just a select few. Among other things, Lipkin is well known for his work with the Covid-19, SARS, and West Nile viruses.

She wished to end the slowness and inefficiency of clinical trials, which had few major actors and were generally inefficient. She thought that everyone should be able to access innovative treatments. CliniBiz claims to bring operational and quality management workflows to manage study operations and partners with investigators to expand new and ongoing research efforts.